ormone-aided scintigraphy: comparison of imaging at multiple times after I-131 administration. // Clin Nucl Med; 2001 26 (5) :392-5
Schicha H., Dietlein M. Radioiodine therapy in differetiated thyroid gland carcinoma. Zentralbl Chir; 1997 122 (4) :266-73
Schlumberger M. I 131 therapy for elevated thyroglobulin levels. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.77
Schlumberger M., Challeton C., De Vathaire F., et al. Radioactive Iodine Treatment and External Radiotherapy for Lung and Bone Metastases from Thyroid Carcinoma. // J Nucl Med; 1996 37 (4) :598-605
Schlumberger M., Pacini F. Thyroid tumors. // Editions Nucleon, Paris, 1999 317pp. p> Schlumberger M.J., Torlantano M. Papillary and follicular thyroid carcinoma. // Baillieres Best Pract Res Clin Endocrinol Metab; 2000 14 (4) :601-13
Schmutzler C. Regulation of the sodium/iodide symporter by retinoids - a review.review. Exp Clin Endocrinol Diabetes. 2001; 109 (1) :41-4. Review. p> Shyh-Ing Guan, Wei-Jen Chang, Ming-Yang Yeh, Wei-Lian Chen. The effect of I-131 radionuclide therapy for carcinoma of thyroid on natural killer cell activity. // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.79
Siddiqi A., Foley R.R., Britton K.E., et al. The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning. // Clin Endocrinol (Oxf); 2001 55 (4) :515-21 p> Simon D., Koehrle J, Reiners C., et al. Redifferentation therapy with retinoids: therapeutic option for advanced follicular and papillary thyriod carcinoma. // World Surg; 1998 22 (6) :569-74
Sisson J., Jamader D., Kazerooni T. at al. 131-I treatment of micronodular lung metastases from papillary thyroid cancer: are the tumor too small? // International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.82
Sisson JC, Giordano TJ, Jamadar DA, et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. // Cancer; 1996 78 (10) :2184-92
Smanik P.A., Cho J-C, Jhiang S.M. Cloning of human sodium/iodine transportet and mechanism of the loss radioiodine uptake activity in thyroid tumors.// International symposium on radioiodine. USA Rochester 1996. Program and Abstracts p.80
Solans R., Bosch J.A., Galofre P., et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. // J Nucl Med; 2001 42 (5) :738-43
Sykes A.J., Gattamaneni H.R. Carcinoma of the thyriod in children: a 25-year experience. // Med Pediatr Oncol; 1997 29 (2) :103-7
Tatar F.A., Morita E., Ituarte P.H., et al. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients. // World J Su...
